UCM126247_(ppt)_Overview of Regulatory Requirements--Medical Devices

开发活动的结构
• • • 没有任何明确的产品开发结构的公司； 有具体过程手册但并没得到遵守的公司； 有结构化的过程但并不能改进或加快开发进度的公司。 a）无章可循的开发活动导致产品不断更改。 b) 由于对必须完成什么样的开发活动及何时完成有误解， 因而造成项目计划 不周、及准备不足。 c) 缺乏通用术语以及由此引起的理解问题，导致开发工作不理想。 d) 产品开发定义过于详细，尤其是缺乏结构的定义，使得开发效率不高。 e) 每一步都有多个签字盖章的官僚过程延缓了开发工作。 f) 缺乏并行工程，因为它没有被设计到结构化开发过程里。 g) 缺乏开发活动的周期时间指导，导致项目进度不准确，
项目小组的构成
• • • • • • • 如果项目小组和职能部门的责权不明确，将造成困惑。 项目小组没有实权去实现目标， 所以效率低； 有时候， 他们只被赋予责任， 却没有相应的权力和资源。 缺乏并行工程，一些职能和技能无法和谐地融入到项目小组的工作中去。 项目领导工作效率低，这源于几个因素：项目领导人没有经验；对项目领 导人角色不明确； 培训不足； 项目领导人更换频繁； 或者项目小组的组织有缺陷。 项目小组缺乏项目实施所需的人手和技能，因而无法实现目标；各种资源 在项目小组间调来换去，对于资源该调拨给哪个项目小组没有明确的决断。 由于没有明确定义项目小组和职能部门之间的协作方法， 两者之间便有冲 突和困扰。 小组成员任务分配造成的困扰使整个小组效率低下；比如说，小组成员把 自己看作职能部门的评估者或记录者，而非真正地帮助进行实时决策。
开发效率低
2 开发质量低
产品开发经常陷入长时 间的签字、扯皮。
产品的稳定性、可生产 性、可维护性不高。
3 开发过程文档质 量低
4
产品过程文档可读性及 可指导性均不强。

2024年全国医疗设备管理新规定英文版Title: New National Regulations for Medical Device Management in 2024In response to the growing need for effective medical device management, the government has introduced new regulations that will come into effect in 2024. These regulations aim to enhance the safety and quality of medical devices used across the country.One of the key changes outlined in the new regulations is the requirement for stricter quality control measures for medical devices. Manufacturers will need to adhere to higher standards to ensure that the devices meet safety and performance requirements. This will help prevent potential risks to patients and improve overall healthcare outcomes.Additionally, the regulations will introduce more comprehensive guidelines for the registration and approval process of medical devices.This will streamline the process and make it more efficient, ensuring that only safe and effective devices are allowed on the market.Furthermore, the new regulations will emphasize the importance of post-market surveillance and monitoring of medical devices. This will help identify any issues or safety concerns that may arise after the devices have been put into use, allowing for timely interventions and corrective actions.Overall, the new national regulations for medical device management in 2024 represent a significant step towards ensuring the safety, quality, and effectiveness of medical devices in the country. These regulations will benefit both healthcare providers and patients by improving the overall standards of care and reducing the risks associated with the use of medical devices.。

医疗器械监督管理条例英文版Regulations on the Supervision and Administration of Medical Devices (English Version)Chapter 1: General ProvisionsArticle 1: These Regulations are formulated to strengthen the supervision and administration of medical devices, ensure their quality and safety, and protect the health and safety of patients and users.Article 2: These Regulations apply to the supervision and administration of medical devices within the territory of the People's Republic of China.Article 3: The State Drug Administration (SDA) is responsible for the supervision and administration of medical devices nationwide. The drug regulatory departments of provinces, autonomous regions, and municipalities directly under the Central Government are responsible for the supervision and administration of medical devices within their respective administrative regions.Chapter 2: Classification and Registration of Medical DevicesArticle 4: Medical devices are divided into three classes: Class I, Class II, and Class III, based on their potential risks to human health.Article 5: Class I medical devices are subject to registration with the SDA or its authorized departments. Class II and Class III medical devices shall obtain a registration certificate from the SDA or its authorized departments before they can be marketed or used.Article 6: The registration of medical devices shall adhere to the principles of scientific evaluation, risk classification, and lifecycle management. The registration procedures and requirements shall be determined by the SDA.Chapter 3: Production and Operation of Medical DevicesArticle 7: The production and operation of medical devices shall comply with relevant laws and regulations, as well as technical standards and requirements.Article 8: Medical device manufacturers shall establish a quality management system in accordance with the Good Manufacturing Practice (GMP) for medical devices. They shall also obtain a Medical Device Manufacturing License before engaging in production activities.Article 9: Medical devices shall be labelled with clear and accurate information, including the name, specifications, model, production date, expiration date, and manufacturer's information.Chapter 4: Clinical Trials and Adverse Event ReportingArticle 10: Clinical trials of medical devices shall be conducted in accordance with the provisions of the relevant regulations. The responsible party shall submit a clinical trial application to the SDA or its authorized departments for approval.Article 11: Any adverse event or abnormal reaction occurring during the use of medical devices shall be reported to the SDA or its authorized departments within the specified time limit.Article 12: Medical device manufacturers and users shall establish a system for monitoring and reporting adverse events. The SDA shall organize the collection, analysis, and evaluation of adverse event information to improve the safety of medical devices.Chapter 5: Supervision and InspectionArticle 13: The SDA and its authorized departments have the authority to conduct supervision and inspection of medical device production, operation, distribution, and use. Relevant units and individuals shall cooperate and provide necessary support during the inspection.Article 14: The SDA and its authorized departments have the power to order the suspension of production, operation, distribution, and use of medical devices that fail to meet the requirements, pose risks to human health, or are suspected of being counterfeit or substandard.Chapter 6: Legal LiabilityArticle 15: Any violation of these Regulations shall be dealt with in accordance with the Drug Administration Law of the People's Republic of China and other relevant laws and regulations.Article 16: Violators who engage in the production and operation of medical devices without obtaining the necessary licenses or registrations shall be subject to administrative penalties, such as fines and confiscation of illegal income. In serious cases, criminal liability shall be pursued.Chapter 7: Supplementary ProvisionsArticle 17: These Regulations shall come into effect on the date of promulgation. The Regulations on the Supervision and Administration of Medical Devices issued by the State Council on January 1, 2002, shall be repealed simultaneously.Article 18: The SDA is responsible for the interpretation of these Regulations.Note: This English version is a translated version for reference purposes only. In case of any discrepancies between the Chinese version and this English version, the Chinese version shall prevail.。

2024年医疗器械安全监管条例英文版Title: Regulations on Medical Device Safety Supervision in 2024In 2024, new regulations on medical device safety supervision will be implemented to enhance the quality and safety standards of medical devices. These regulations aim to protect public health and ensure that medical devices meet the necessary safety requirements.The regulations will cover various aspects of medical device safety, including manufacturing standards, quality control measures, post-market surveillance, and reporting of adverse events. Manufacturers will be required to comply with these regulations to ensure that their products are safe for use by patients.Additionally, the regulations will establish a framework for regulatory authorities to monitor and supervise the safety of medical devices in the market. This will involve conducting regular inspections,audits, and reviews of manufacturers to ensure compliance with safety standards.Furthermore, the regulations will include provisions for the reporting of adverse events related to medical devices. Manufacturers, healthcare providers, and patients will be required to report any incidents of device malfunction, injury, or death to the regulatory authorities for investigation.Overall, the regulations on medical device safety supervision in 2024 will play a crucial role in ensuring the quality and safety of medical devices in the market. By upholding stringent safety standards and regulatory oversight, these regulations will help protect patients and promote public health.。